University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Modelling the cost-effectiveness of adopting risk stratified approaches to extended screening intervals in the national diabetic retinopathy screening programme in Scotland

dc.contributor.authorScotland, G.
dc.contributor.authorMcKeigue, P.
dc.contributor.authorPhilip, S.
dc.contributor.authorLeese, G. P.
dc.contributor.authorOlson, J. A.
dc.contributor.authorLooker, H. C.
dc.contributor.authorColhoun, H. M.
dc.contributor.authorJavanbakht, M.
dc.contributor.institutionUniversity of Aberdeen.Health Economics Research Uniten
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Evaluationen
dc.date.accessioned2017-07-01T23:03:40Z
dc.date.available2017-07-01T23:03:40Z
dc.date.embargoedUntil2017-05-11
dc.date.issued2016-07
dc.descriptionFunding sources: The study was funded by a research grant from the Chief Scientist’s Office of the Scottish Government Health and Social Care Directorates (CZH/4/971). The funder played no role in study design, data collection, data analysis, manuscript preparation and/or publication decisions. The views expressed herein are those of the authors and do not necessarily reflect those of the funder. Acknowledgements: The authors would like to thank Drs Vijay Hegde (NHS Grampian), William Wykes, Sonia Zachariah (NHS Glasgow), Karin Madill (NHS Lothian), Caroline Styles (NHS Fife), Mohan Varikkara (NHS Ayrshire and Arran), and Brian Power (NHS Dumfries and Galloway) for providing information on their current clinical practice for dealing with referrals from the diabetic retinopathy screening programme in Scotland.en
dc.description.statusPeer revieweden
dc.format.extent10
dc.format.extent286958
dc.identifier64964293
dc.identifierbeb46b37-4887-4dff-a140-ebb512ac934c
dc.identifier84975165637
dc.identifier.citationScotland, G, McKeigue, P, Philip, S, Leese, G P, Olson, J A, Looker, H C, Colhoun, H M & Javanbakht, M 2016, 'Modelling the cost-effectiveness of adopting risk stratified approaches to extended screening intervals in the national diabetic retinopathy screening programme in Scotland', Diabetic Medicine, vol. 33, no. 7, pp. 886-895. https://doi.org/10.1111/dme.13129en
dc.identifier.doi10.1111/dme.13129
dc.identifier.iss7en
dc.identifier.issn0742-3071
dc.identifier.urihttp://hdl.handle.net/2164/8904
dc.identifier.vol33en
dc.language.isoeng
dc.relation.ispartofDiabetic Medicineen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectR Medicineen
dc.subjectChief Scientist Office (CSO)en
dc.subjectCZH/4/971en
dc.subjectSupplementary Dataen
dc.subject.lccRen
dc.titleModelling the cost-effectiveness of adopting risk stratified approaches to extended screening intervals in the national diabetic retinopathy screening programme in Scotlanden
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Scotland_et_al_2016_Diabetic_Medicine.pdf
Size:
280.23 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
8.29 KB
Format:
Plain Text
Description: